Literature DB >> 30663091

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.

Yasuya Tashiro1, Hiroaki Azukizawa2, Hideo Asada2, Hiroyuki Niihara3, Eishin Morita3, Teruo Yamauchi1, Yoshiko Mizukawa4, Yoshio Kusakabe5, Satoshi Numazawa6, Miki Izumi7, Hirohiko Sueki1, Hideaki Watanabe1.   

Abstract

Drug-induced hypersensitivity syndrome (DIHS), also referred to as drug reaction with eosinophilia and systemic symptoms (DRESS), is a multi-organ systemic drug reaction characterized by hematological abnormalities and reactivation of human herpesvirus-6 (HHV-6). DIHS/DRESS is typically associated with a limited number of drugs, such as the anticonvulsants. Our group has treated 12 patients for DIHS/DRESS due to lamotrigine (LTG), but their presentation differed from that of patients with DIHS/DRESS caused by other drugs. The aim of the present study was to identify significant differences between DIHS/DRESS caused by LTG versus other drugs. We retrospectively reviewed data of 12 patients with DIHS/DRESS caused by LTG and 32 patients with DIHS/DRESS due to other drugs. The increase in alanine aminotransferase level was significantly milder in the LTG group than the DIHS/DRESS group due to other drugs. The percentage of atypical lymphocytes in the blood during DIHS/DRESS was lower in the LTG group. Serum levels of lactate dehydrogenase and thymus and activation-regulated chemokine were also lower in the LTG group. There were fewer DIHS/DRESS patients with HHV-6 reactivation in the LTG group than in the group treated with other drugs. Lymphocyte transformation after DIHS/DRESS onset was faster in the LTG group. The two groups did not differ with respect to the interval from first drug intake to rash, white blood cell count, blood eosinophilia or DRESS score. There were no significant histopathological differences between the two groups. The features of LTG-associated DIHS/DRESS and DIHS/DRESS due to other drugs differ.
© 2019 Japanese Dermatological Association.

Entities:  

Keywords:  drug reaction with eosinophilia and systemic symptoms; drug-induced hypersensitivity syndrome; human herpes virus 6; lamotrigine; thymus and activation-regulated chemokine

Mesh:

Substances:

Year:  2019        PMID: 30663091     DOI: 10.1111/1346-8138.14776

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

1.  Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.

Authors:  Natsumi Hama; Riichiro Abe; Andrew Gibson; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-15

Review 2.  Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy.

Authors:  Enes Akyüz; Betül Köklü; Cansu Ozenen; Alina Arulsamy; Mohd Farooq Shaikh
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 3.  Approach to Patients with Eosinophilia.

Authors:  Fei Li Kuang
Journal:  Med Clin North Am       Date:  2020-01       Impact factor: 5.456

Review 4.  Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.

Authors:  Luckshman Ganeshanandan; Michaela Lucas
Journal:  Int J Mol Sci       Date:  2021-01-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.